00000nam 2200000zi 4500 9.883227 CaOODSP 20221107170515 m o d f cr |n||||||||| 191231t20202020onc ob f|0| 0 eng d 9780660336589 CaOODSP eng rda CaOODSP n-cn--- H14-342/2020E-PDF Annex 3B to the good manufacturing practices guide : positron-emitting radiopharmaceuticals (GUI-0071). [Ottawa] : Health Canada = Santé Canada, 2020. ©2020 1 online resource (34 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Annexe 3B aux Lignes directrices sur les Bonnes pratiques de fabrication : produits radiopharmaceutiques émetteurs de positrons. Issued also in HTML format. "September 15, 2020." "Replaces: Annex to the Good Manufacturing Practices Guidelines Good Manufacturing Practices (GMP) for Positron Emitting Radiopharmaceuticals (PERs) (GUI-0071), February 15, 2006." Includes bibliographical references (pages 33-34). Drug factories Canada. Radiopharmaceuticals Canada. Canada. Health Canada, issuing body. Annexe 3B aux Lignes directrices sur les bonnes pratiques de fabrication : (CaOODSP)9.883229 PDF 1.45 MB https://publications.gc.ca/collections/collection_2021/sc-hc/H14-342-2020-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-manufacturing-practices-positiron-emitting-radiopharmaceuticals/document.html Pub.: 190532